Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine
Cécile Viboud(National Institutes of Health), David Spiro(National Institutes of Health), Martha I. Nelson(United States National Library of Medicine), Amanda C. Perofsky(National Institutes of Health), Katelyn M. Gostic(University of California, Los Angeles), Benjamin J. Cowling(University of Hong Kong), Kaiyuan Sun(National Institutes of Health), Graeme E. Price(Center for Biologics Evaluation and Research), Nídia S. Trovão(National Institutes of Health), Suzanne L. Epstein(Center for Biologics Evaluation and Research)
Cited by 35
Related Papers
The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak
|Science|2020|4k
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3k
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study
|The Lancet Infectious Diseases|2014|965
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study
|The Lancet Infectious Diseases|2020|720